Table 1.
Demographic and clinical characteristics in patients with endometrial cancer (n =88)
| Parameter | Number |
|---|---|
| Age (years) (mean ± SD) | 65 ± 8 |
| <60 | 39 (44.3%) |
| ≥60 | 49 (55.7%) |
| BMI, kg/m2 (mean ± SD) | 27 ± 8 |
| BMI <30 kg/m2 | 48 (54.5%) |
| BMI ≥ 30 kg/m2 | 40 (45.5%) |
| Hypertension,n(%) | 9 (10.2%) |
| Diabetes, n(%) | 10 (11.4%) |
| Hormonal treatment | 20 (22.7%) |
| Prior breast cancer, tamoxifen treatment | 0 (0%) |
| Cancer stagea | |
| IA n(%) | 33 (37.5%) |
| IB n(%) | 25 (28.4%) |
| II n(%) | 21 (23.9%) |
| IIIA–IIIC n(%) | 7 (8%) |
| IVA–IVB n(%) | 2 (2.3%) |
| Cancer type | |
| Endometrioid n(%) | 68 (77.3%) |
| Serous n(%) | 18 (20.5%) |
| Carcinosarcomas n(%) | 2 (2.3%) |
BMI, body mass index; SD, standard deviation.
a
International Federation of Gynecology and Obstetrics (FIGO) 2009 staging criteria.19,20